Item 7.01. Regulation FD Disclosure. On January 11, 2021, Surface Oncology, Inc. (the "Company") issued a press release titled "Surface Oncology to Participate in H.C. Wainwright Bioconnect 2021 Conference." A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 7.01 and Exhibit 99.1 attached hereto are intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.




Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.

Exhibit
Number                                                 Description

99.1                      Press release issued by Surface Oncology, Inc. on January 11, 2021




                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses